World Organ Transplant Day: From 3D Printing To Lab-Grown Organs, Transplant Breakthroughs Are Here

Updated Aug 13, 2025 | 05:20 PM IST

SummaryOn World Organ Transplant Day, while donor shortages persist, breakthroughs in 3D bioprinting, artificial organs, and bioengineering offer hope of reducing waiting lists, improving patient outcomes, and transforming transplants into a future where “no donor” does not mean “no chance”.
Credits: Canva

On World Organ Transplant Day, we usually hear about the urgent need for more donors, the lifesaving power of a transplant, and how one person’s decision can save up to eight lives. That is all still true and still critical but here is the twist: while the waiting lists grow, so do the technologies that might one day make them shorter or even unnecessary.

The future of organ transplantation is not just beating in donor hearts anymore; it is also whirring in lab incubators, spinning in magnetic rotors, and taking shape layer by layer on 3D bioprinters.

Despite decades of successful surgeries, the biggest roadblock in transplantation remains supply. Dr Bipin Chevale, CEO of Gleneagles Hospital Mumbai, explains, “There is still a persistent disparity between organ supply and demand. In India, thousands remain on waiting lists, and many lose their lives before a suitable organ becomes available.”

The reasons are a blend of low awareness, cultural taboos, and plain logistical hurdles. In 2023–24, nearly 50,000 Indians were waiting for organ replacement, according to the National Organ and Tissue Transplant Organisation (NOTTO). Globally, the US alone has more than 100,000 patients on transplant lists, with 13 lives lost every day while waiting.

Medical science, however, has been busy building backup plans. From 3D printing body parts to developing fully artificial organs, scientists are inching closer to a future where “no donor” does not mean “no hope”.

The Rise of 3D Bioprinting

Specialised 3D bioprinters can lay down living cells in precise patterns to create tissue that looks and behaves like the real thing.

Dr Varun Mittal, Head of Kidney Transplant at Artemis Hospitals, says researchers have “made great strides in printing living tissues and complicated networks of blood vessels”, something previously thought impossible. Techniques like Co-SWIFT create branching vessels inside heart tissue, while 3D ice printing uses water and gelatine to make smooth vessel templates.

While we are not yet popping out fully functional hearts or kidneys from printers for surgical use, these technologies are already valuable for training surgeons, testing drugs, and inching toward patient-specific implants. The idea is to design an organ to match a patient’s exact size, shape, and immune profile, dramatically lowering the risk of rejection.

Artificial Organs: Machines That Act Human

If printing an organ from scratch is the long game, artificial organs are the fast-forward button. These mechanical or bioengineered devices can take over the job of a failing organ, sometimes temporarily, sometimes for months or years.

One striking example is the BiVACOR artificial heart. It does not beat; it spins. A magnetic rotor pumps blood continuously, acting as a bridge until a donor heart is found. Dr Mittal points out that some patients have survived for months with the device, staying mobile and alert while awaiting surgery.

Similarly, researchers are developing implantable bioartificial kidneys that could filter blood and house living kidney cells without the need for dialysis or lifelong immunosuppressants. Wearable dialysis units are also in the works, aimed at freeing patients from hours tethered to clinic machines.

The Lung and Liver Challenge

Some of the boldest experiments are happening with lungs and livers, two of the trickiest organs to replace due to their complexity.

Dr Yasir Rizvi, Director of Nephrology and Kidney Transplant at Dharamshila Narayana Superspeciality Hospital, points to a landmark in lung research: a 3D-printed human-scale scaffold containing about 4,000 km of capillaries across 44 trillion voxels. In animal studies, it has already exchanged gases like a natural lung.

For the liver, bioprinting and bioengineering efforts aim to create functional tissue that can sustain patients until a full transplant is possible or even act as a permanent fix in the future.

The Benefits Are Already Here

We may still be a few years from printing a fully functional, transplant-ready heart, but artificial organ technology is already improving lives. Pacemakers, cochlear implants, and ventricular assist devices, these are all proof that machinery and biology can coexist in the human body.

Artificial organs have the potential to:

  • Reduce rejection by using a patient’s own cells
  • Cut waiting times dramatically
  • Lower long-term medical costs by reducing hospital stays
  • Give access to treatment in regions where donor organs are scarce

As Dr Chevale says, these breakthroughs are only half the story. “Their success will also depend on increasing awareness about organ donation, busting myths, and encouraging more people to pledge their organs.”

The Ethical Road Ahead

Of course, the march toward lab-grown and artificial organs comes with big ethical questions. Who gets them first? Will they be affordable or only for the wealthy? How do we ensure safety in devices meant to live inside fragile bodies?

Dr Rizvi believes that with “careful regulation, transparent trials and patient-centred design, these innovations can turn prototypes into standard care”. In India, collaborations between AIIMS, IITs, and bio-technical start-ups are already laying the groundwork, with the hope of producing affordable devices for both domestic and global use within a decade.

A Future Worth Donating To

Even if the day comes when a printer can make you a brand-new kidney, organ donation will still matter. Research organs, temporary implants, and hybrid solutions will always benefit from donated tissue to validate safety and function.

The future of transplantation is no longer just a race against the clock for a donor organ, it is also a race to develop, print, and perfect replacements that can save lives anywhere, anytime.

End of Article

40-Year-Old Thought He Had Flu But It Was A Rare Autoimmune Disease Failing His Kidneys: What Is Goodpasture Syndrome

Updated Nov 18, 2026 | 11:00 PM IST

SummaryGoodpasture Syndrome, also known as anti-glomerular basement membrane disease (anti-GBM disease), can result in severe organ damage, especially lungs and kidneys.
40-Year-Old Thought He Had Flu But It Was A Rare Autoimmune Disease Failing His Kidneys: What Is Goodpasture Syndrome

Credit: AI

What initially seemed like an ordinary flu turned into a life-threatening medical emergency for a 40-year-old man in the UK, who discovered that his kidneys were failing because of a rare autoimmune disease.

Swaroop Kadambari, a financial services lawyer and father of three, initially dismissed his constant exhaustion, fever and nausea as signs of a viral influenza infection. But blood tests revealed that his kidneys were severely damaged.

Further investigations identified a rare condition called anti-glomerular basement membrane disease (anti-GBM disease).

Kadambari’s diagnosis highlights how some autoimmune diseases can cause severe organ damage while presenting with symptoms that may appear common.

According to The Telegraph, Kadambari was 37 when his symptoms first surfaced in 2023. He had started feeling excessively tired, struggled to stay awake in the evenings and found it difficult to maintain his usual exercise routine. His face also became puffy and he experienced prolonged nausea.

When he developed fever and vomiting, he assumed he had the flu. It was his wife, Tanya, who encouraged him to visit his general practitioner (GP).

Blood test results prompted his doctor to send him to hospital immediately. Within three days, doctors diagnosed him with anti-GBM disease.

Also read: Christina Applegate Suspects Breast Implants May Have Caused MS-Like Symptoms: What Is the Condition?

What Is Anti-GBM Disease?

Anti-glomerular basement membrane disease is a rare autoimmune disorder in which the body's immune system mistakenly produces antibodies that attack the basement membranes of small blood vessels, spoecifically those in the kidneys and lungs.

The glomerular basement membrane is a thin layer of tissue that forms part of the kidney's filtration system. It helps filter waste from the blood while retaining essential proteins and blood cells.

When antibodies attack this membrane, they cause inflammation and damage to the kidney's filtering system, known as glomeruli. This can lead to progressive kidney failure.

The condition can also affect the lungs by damaging small blood vessels in the air sacs, causing bleeding in the lungs.

When anti-GBM disease affects both the kidneys and lungs, it is commonly referred to as Goodpasture syndrome.

Also read: Nick Jonas Opens Up About Living With Type 1 Diabetes For More Than 2 Decades: What Does It Entail

Symptoms Of Anti-GBM Disease

One of the challenges with anti-GBM disease is that its early symptoms can be mistaken for those of common infections. Some warning signs include:

  • Chronic fatigue and weakness
  • Fever and nausea
  • Swelling around the face, hands or legs
  • Blood in the urine
  • Decreased urine output
  • Breathlessness or coughing up blood if lungs are affected

Also read: ‘Grey’s Anatomy’ Star Opens Up About Hashimoto’s Hypothyroidism: Know How This Autoimmune Disorder Can Impact Body and Mind

How Is Anti-GBM Disease Treated?

Treatment aims to stop the immune system from producing harmful antibodies and remove those already circulating in the bloodstream.

Kadambari underwent plasmapheresis, a procedure that removes the patient's blood plasma containing harmful antibodies and replaces it with donor plasma. He also received medicines to suppress his immune system and reduce further damage.

Despite undergoing 14 sessions of plasmapheresis over two weeks, his kidney function continued to deteriorate. After six weeks, a kidney biopsy confirmed that his kidneys were no longer functioning, making regular dialysis necessary.

He eventually became eligible for a kidney transplant after receiving rituximab, a medicine that helps combat antibody-producing immune cells.

Kadambari depended on dialysis to survive for the next year. Initially, he received treatment in hospital and later continued it at home with his wife's help.

In May 2024, approximately a year after his first hospitalisation, Tanya donated one of her kidneys to him after being found to be a suitable match.

The transplant allowed him to stop dialysis and return to a more normal routine.

End of Article

World COPD Day: Even As Delhi's Air Pollution Declines, These Overlooked Factors Can Raise Your COPD Risk

Updated Nov 18, 2026 | 04:00 PM IST

SummaryOn World COPD Day, do not ignore lesser-known risk factors around you that can make you more susceptible to chronic obstructive pulmonary disease like cooking smoke, second-hand smoke, dust and others.
COPD Day: Even As Delhi's Air Pollution Declines, These Overlooked Factors Can Raise Your COPD Risk

Credit: AI image

Delhi’s disastrous air quality after Diwali sparked concerns due to the numerous health threats it posed. The AQI of the national capital crossed 400 and remained in that vicinity for days that followed. But on Tuesday, as the temperature dropped, the city’s AQI also seemed to improve.

The AQI lowered enough for the Commission for Air Quality Management (CAQM) to revoke GRAP III rules, though it remained in the ‘poor’ category.

The 24-hour average air quality index (AQI) improved for three consecutive days, falling from 400 during and post Diwali to 204, according to the Central Pollution Control Board (CPCB)’s 4pm reading. It marked Delhi’s best air quality in November and the best since October 31 when 24-hour AQI was 117 (moderate).

But the improvement in AQI does not mean that the residents no longer face respiratory risks. Stage I and II restrictions still remain in force, which means Delhi's air quality is still in the 'poor' category. So as the world observes World COPD Day on November 18, we explore why people would still be at chronic obstructive pulmonary disease (COPD) risk despite improving pollution levels.

This year's theme, "Early Diagnosis and Management for a Better Life," focuses on the importance of identifying symptoms and risks before extensive lung damage occurs.

What Is COPD And Why Is It A Concern?

COPD is a chronic lung disease that restricts airflow, making it difficult to breathe. It includes two conditions: chronic bronchitis, which is long-term inflammation of the airways and excess mucus production, and emphysema, in which the tiny air sacs in the lungs become damaged.

While smoking is widely recognised as a major cause of COPD, it is not the only one. According to India’s Ministry of Health, exposure to household cooking smoke, dust, chemical fumes and even respiratory infections during childhood can contribute to it.

According to the World Health Organization (WHO), COPD caused approximately 3.4 million deaths worldwide in 2023, making it the third-leading cause of death globally. Although COPD cannot be cured, early diagnosis, treatment and reducing exposure to risk factors can help slow disease progression.

Also read: As Delhi's PM2.5 Pollution Soars 2.3 Times The National Standard, Experts Explain Why You May Be Sleeping Poorly

Overlooked Factors That Can Increase Your COPD Risk

1. Household cooking smoke

Cooking with traditional fuels like wood, coal, crop residue and animal dung can release harmful particles and gases into the air. Long-term exposure in poorly ventilated kitchens can damage the respiratory system over time.

2. Exposure to dust and chemicals

People working in construction, mining, agriculture, textile manufacturing and industries involving chemicals may regularly inhale dust, fumes and other respiratory irritants.

Exposure to pollutants like silica, coal dust, cotton dust, welding fumes and industrial chemicals can cause chronic inflammation and damage to the airways.

3. Secondhand smoke

You do not have to smoke yourself to experience the harmful effects of tobacco. Regular exposure to second-hand cigarette smoke in shared spaces can also irritate the airways and contribute to respiratory inflammation.

Also read: Lung Cancer In Non-Smokers: AIIMS Oncologist Says Cases Are Rising Among Young People And Women, Explains PM2.5 Link

4. Repeated respiratory infections during childhood

The foundations of lung health are established early in life. Severe or frequent respiratory infections during childhood can interfere with normal lung development and prevent children from reaching their full lung capacity.

The WHO identifies early-life diseases like premature birth, poor growth in the womb and repeated childhood respiratory infections as COPD risk factors. Childhood asthma can also increase the risk of developing chronic airflow obstruction in adulthood.

5. Genetic factors

In some people, COPD develops partly because of inherited genetic factors. One example is alpha-1 antitrypsin deficiency, a rare disorder in which the body does not produce enough of a protein that protects lung tissue from damage.

Without adequate protection, lung tissue can become damaged, increasing the risk of emphysema and COPD.

Also read: 91% Of Indian Studies Spanning 50 Years Link Air Pollution To Diabetes, Heart Disease And Cancer

Can Delhi's Air Pollution Increase COPD Risk Even If AQI Improves?

A temporary dip in air pollution levels does not reverse the effects of prolonged exposure to air pollution. Fine particulate matter like PM2.5, can penetrate deep into the lungs and trigger inflammation.

Long-term exposure can contribute to airway damage, worsen existing respiratory issues and increase the risk of developing chronic respiratory diseases.

According to WHO, outdoor air pollution is among the major risk factors for COPD, alongside tobacco smoke and household air pollution.

Reducing exposure to harmful substances is key to preventing COPD. Quitting smoking, avoiding secondhand smoke, switching to cleaner cooking fuels, improving workplace ventilation and using appropriate respiratory protection can help reduce risk.

People with chronic respiratory issues should consult a doctor rather than dismissing breathlessness or a chronic cough as normal.

End of Article

From 365 To 52: How Simplifying Treatment Can Transform Diabetes Care In India

Updated Nov 18, 2026 | 02:00 PM IST

SummaryManaging diabetes often involves multiple daily medications, injections and constant monitoring. Simplifying treatment routines could reduce treatment fatigue, improve adherence and transform diabetes management for millions of Indians.
From 365 To 52: How Simplifying Treatment Can Transform Diabetes Care In India

Credit: AI image

For many people living with chronic conditions, the hardest part of treatment is not understanding what to do, but managing the daily effort required to do it. When a health routine demands multiple pills, frequent injections, and rigid schedules, treatment fatigue quickly sets in.

Over time, complicated routines lead to missed doses, inconsistent control, and growing frustration. This is not a personal shortcoming or a lack of discipline; it is simply what happens when medical care creates too much friction in everyday life.

India’s Growing Diabetes Burden

This challenge is clearly visible in India’s diabetes landscape. Data from the ICMR-INDIAB study revealed that more than 10.1 crore people in India live with diabetes, and another 136 million have prediabetes. Additionally, findings from the National Family Health Survey (NFHS-6) show that elevated blood sugar is rising rapidly across both cities and rural areas.

Despite increased awareness of Type 2 Diabetes, more than 80% of people undergoing treatment continue to have blood sugar levels above the recommended target, as reflected by Glycated Hemoglobin (HbA1c) levels of 7% or higher. HbA1c reflects the average blood sugar levels over the past three months. Type 2 Diabetes is a progressive disease, and as the condition advances, many individuals may eventually require insulin therapy to manage their blood sugar levels.

Also read: World Diabetes Day 2026: Is India's Toxic Air Adding To Its Diabetes Crisis? What Experts Say

Why Patients Delay Starting Insulin

A primary contributor to this gap is the delay in starting essential therapies. On average, patients in India wait nearly 8.8 years before starting basal insulin. The hesitation stems from clear concerns: up to 93% of patients report a strong dread of daily needle pricks, while healthcare providers observe that hectic work and family schedules make daily injections difficult to sustain. During these years of delay, unmanaged high blood sugar silently raises the risk of long-term damage to the heart, kidneys, nerves, and eyes.

Across modern medicine, research shows that simpler treatment plans consistently produce better outcomes. In cardiovascular care combining multiple medications into a single once-daily pill significantly improved adherence and reduced hospital visits.

In metabolic health, long-acting, sustained-release tablets replaced the need to remember multiple midday doses. Whenever therapies adapt to human routines rather than forcing individuals to reorganize their days, patients stay on treatment longer and achieve steadier health results.

Also read: Effect of Diabetes on Different Organs: Why the Damage Is Not the Same Everywhere

Once-Weekly Insulin: A Shift In Diabetes Management

For over a century, basal insulin had to be administered as a once-daily injection with some cases, twice a day. Today, that clinical approach has shifted. Insulin Icodec, the world’s first once-weekly basal insulin analogue, was engineered specifically around the need for simplicity. Its formulation attaches to a neutral carrier protein - albumin- in the bloodstream, forming an inactive reserve that steadily releases active insulin across seven full days.

This design reduces the basal insulin injection burden seven-fold, cutting injections from 365 a year down to just 52. Administered once a week through a FlexTouch® pen, this simpler routine does not compromise effectiveness. In the global clinical trial program “ONWARDS”, once-weekly insulin icodec demonstrated superior HbA1c reductions and significantly more Time-in-Range compared to standard once-daily basal insulin (glargine U100). Additionally, adults with type 2 diabetes were 49% more likely to reach HbA1c below 7% with insulin icodec without experiencing clinically significant or severe low blood sugar.

Managing diabetes should never feel like a second job. When healthcare becomes less complicated, living well becomes far more achievable. If injection fatigue, busy schedules, or needle anxiety have delayed blood sugar control, simpler medical options now exist. Speaking with a doctor about simplifying daily care is an effective first step toward lasting health.

End of Article